Clinical Trials Directory

Trials / Completed

CompletedNCT07176585

A Prospective, Single-site, Single-group Value Study on the Diagnosis of Functional Myocardial Ischemia Based on IVUS Plaque Characteristics

Status
Completed
Phase
Study type
Observational
Enrollment
105 (actual)
Sponsor
Insight Lifetech Co., Ltd. · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate the accuracy of IVUS-calculated percent atheroma volume (PAV) for diagnosing functional myocardial ischemia, using FFR as the gold standard.

Detailed description

This prospective, single-site, single-group target-value study aims to investigate the accuracy of intravascular ultrasound (IVUS)-based plaque characteristics in diagnosing functional myocardial ischemia, using coronary fractional flow reserve (FFR) as the gold standard.

Conditions

Timeline

Start date
2025-09-23
Primary completion
2026-01-04
Completion
2026-01-04
First posted
2025-09-16
Last updated
2026-01-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07176585. Inclusion in this directory is not an endorsement.